The Australian National Advisory Council on Alcohol and Drugs (ANACAD) has funded NDARC to conduct a feasibility study for an early warning system (EWS) project, involving a data collection model that allows rapid triangulation of existing data to provide an early warning and current assessment o
This project is an international collaboration to assess the nature and extent of health outcomes from drug cryptomarkets, globally and specifically for Australians.
Cannabis remains one of the most commonly used psychoactive substances in the United States, and current epidemiological studies indicate broadening acceptability. This aim of this project is to decrease the burden of psychoactive substance use in the US.
To reduce alcohol related harms, the World Health Organisation recommends regulating the sale and supply of alcohol, including limiting the number of premises selling alcohol as well as the hours during which alcohol can be sold.
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
It has been argued that the increased influence of conservative advocacy groups and the impact of the political social conservatism of ‘The Howard Years’ has led to a conservative shift in Australian drug policy, away from harm minimisation and towards a zero tolerance model (Mendes, 2001,
Changes to the status of cannabis, ranging from legalisation through to tougher enforcement of prohibition are frequently posed. To date, the debate has centred on arguments associated with liberty and harm, but not on economic analyses.
The purpose of this project was to summarise what is known internationally, nationally and in NSW about unmet need and unmet demand for OTP in NSW and provide some initial estimates for NSW.